GPT HEALTHCARE IPO NEWS
At $4.2 billion, Q2 2024 IPO size records its highest growth in 2 years
QIPs saw a rise in both value and volume compared to the previous quarter, with 20 issues raising $2.3 billion. This marks the second-highest volume since Q4 2017. The retail and consumer sector led deal activity, with an 18% increase in value over Q1 2024, despite a 7% decrease in volume.
Health insurer Niva Bupa, Sagility India files draft papers with Sebi for IPOs
The IPO, with each share having a face value of Rs 10, consists of a fresh issuance worth Rs 800 crore and an offer for sale totaling up to Rs 2,200 crore by the promoters and existing investors. As part of the OFS, Bupa Singapore Holdings and Fettle Tone will be divesting their stakes.
73% IPOs trading above issue price as primary market shines in H1, four turn multibaggers
The fundraising of Rs 26,272 crore, however fell short of the previous two years likely due to the absence of mega issues. Investors' reception also remained positive with only one failed IPO.
Insurer Niva Bupa plans $360 million IPO: Report
British United Provident Association (Bupa), which holds a 63% stake in the Indian venture, plans to sell a small stake worth up to $38 million and Indian private equity firm True North is planning a stake sale worth up to $225 million, the document detailing the IPO plans showed.
3C IT Solutions IPO opens today: Check issue size, price band, GMP and other details
The SME IPO of 3C IT Solutions will open today, aiming to raise Rs 11.44 crore. India's GII ranking improved to 40th position, making it a top offshoring destination for IT companies. Kreo Capital is the lead manager for the IPO.
GPT-4o set to disrupt conversational AI, edtech and call centre business
ChatGPT creator OpenAI announced the launch of GPT-4o, its newest flagship model, during a livestream on Monday. Chief technology officer Mira Murati described GPT-4o as "much faster" and "improves capabilities across text, vision, and audio".
- Go To Page 1
Indegene stock debuts with 46% premium over issue price
Indegene's stock debuts at Rs 659.7, a 46% premium over the issue price. The IPO, oversubscribed 70 times, raised funds for debt and capital expenditure. Revenue reached Rs 1,969 crore for the period ending December 2023.
Indegene IPO booked over 10x so far on Day 3. Check subscription, GMP and other details
Indegene IPO GMP: On the final day of the initial public offer (IPO), Indegene was booked a little over 10 times so far on Wednesday, the last day of the bidding process.
Shares worth $21 billion to enter market in 4 months as IPO lock-in period expires for 66 companies
66 companies are set to see the lock-in period for pre-listing shareholders lifted between March 4 and June 29. This amounts to $21.1 billion in value terms. The value pertains to the total lock-up opening shares, but not all the shares may be sold, as a sizable portion is also held by promoters and group entities
GPT Healthcare debut exceeds expectations. Should you wait for more upside?
The shares of GPT Healthcare debuted with a 15% premium over the issue price on Thursday, which was slightly above expectations. Most analysts priced in a 9-10% premium listing.
GPT Healthcare shares list at 16% premium over IPO price
GPT Healthcare Share Price: GPT Healthcare's IPO debuted with a 16.2% premium. It raised Rs 525 crore for prepayment/repayment of borrowings. The company operates four multispecialty hospitals. Revenue grew at 53.87% CAGR. Three-month total income was Rs 97.63 crore, net profit was Rs 9.98 crore.
Stocks in news: RIL, Shriram Finance, GPT Healthcare, Coal India, Oil India
Shriram Finance Ltd will replace UPL Ltd in benchmark Nifty 50 index with effect from March 28, the National Stock Exchange said on Wednesday.
GPT Healthcare to debut tomorrow. Here's what GMP indicates ahead of listing
The shares of GPT Healthcare will debut on the exchanges on Thursday. Ahead of the listing, the company's shares are trading with a premium of Rs 17 in the unlisted market.
GPT Healthcare IPO allotment: Check status, listing date, GMP and other details
GPT Healthcare IPO received 8.5 times subscription. Share allotment to be finalized. Check status on BSE or registrar website. Shares trading with Rs 10 premium. Proceeds used for repayment. Competing with listed peers. JM Financial is the sole book running lead manager.
GPT Healthcare IPO fully subscribed on last day. Check GMP and other details
In the unlisted market, the company's shares are trading with a premium of Rs 10, marginally up from the previous week.
GPT Healthcare IPO: Check subscription on Day 2, GMP and other details
The proceeds from the fresh issue will be used for prepayment or repayment of all or a portion of certain outstanding borrowings availed by the company besides general corporate purposes.
GPT Healthcare IPO: Check subscription on Day 1, GMP and other details
GPT Healthcare IPO is priced at Rs 177-186 per share for its Rs 525-crore IPO. Investors can make bids for 80 shares in one lot and its multiples thereafter.
GPT Healthcare IPO opens for subscription. Should you apply?
GPT Healthcare IPO: GPT Healthcare's IPO, valued at Rs 525 crore, opened for subscription. The company raised Rs 157 crore from anchor investors. Analysts advise subscribing for fair valuations, comprehensive services, and quality medical practices. The price band is Rs 177-186 per share.
GPT Healthcare has promising prospects, but wait for listing to get clearer picture
Set up in 2000 as an eight-bed hospital at Salt Lake in Kolkata by laparoscopic surgeon Dr Om Tantia, the company now operates four secondary and tertiary care hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of 561 beds.
GPT Healthcare garners Rs 157 cr from anchor investors ahead of IPO
GPT Healthcare Ltd, which operates and manages mid-sized multi-specialty hospitals under the ILS Hospitals brand, on Wednesday collected Rs 157.54 crore from anchor investors a day before its Initial Public Offering (IPO).
GPT Healthcare IPO to open on Thursday. What GMP signals ahead of subscription?
GPT Healthcare has fixed a price band of Rs 177-186 per share for its Rs 525-crore IPO. The issue closes on February 26. Investors can make bids for 80 shares in one lot and multiples thereafter. The proceeds will be used for prepayment or repayment of all or a portion of certain outstanding borrowings availed by the company and for general corporate purposes.
GPT Healthcare sets price band of Rs 177-186 for its Rs 525-cr IPO
The IPO is a combination of a fresh issue of equity shares aggregating to Rs 40 crore and an Offer For Sale (OFS) of up to 2.6 crore equity shares by private equity firm BanyanTree Growth Capital II.
Kolkata-based GPT Healthcare announces IPO dates. Check details
The IPO, with a face value of Rs 10, consists of a fresh issue of equity shares, aggregating to Rs 40 crore, and an offer for sale (OFS) of up to 2.6 crore equity shares by BanyanTree Growth Capital II, LLC, a Mauritius-based structured private equity.
GPT Healthcare's IPO to open on Feb 22; PE firm BanyanTree Growth Capital to exit
The IPO is a combination of a fresh issue of equity shares aggregating to Rs 40 crore, and an Offer For Sale (OFS) of up to 2.6 crore equity shares by private equity firm BanyanTree Growth Capital II.
Entero Healthcare IPO fully subscribed on final day. Check subscription, GMP and other details
Entero Healthcare IPO comprises a fresh equity issue of Rs 1,000 crore and an OFS of up to 47.69 lakh shares. Prabhat Agrawal, Prem Sethi, Orbimed Asia Iii Mauritius, Chethan MP, and Deepesh T Gala, among others, will offload shares under the OFS. The shares are trading with a marginal premium of Rs 10 in the grey market.
Entero Healthcare IPO sees tepid response. Check subscription, GMP, and other details
Entero Healthcare IPO price band has been fixed from Rs 1,195-1258 per equity share. Bids can be made for a minimum of 11 shares and in multiples thereafter. the shares are trading with a marginal premium of Rs 5 in the grey market.
Massive growth opportunities for healthcare industry in India: Entero Healthcare MD
“Our business model is very simple. We are one of the largest distributors of healthcare products in this country. Basically, we buy from 1900 different companies today and supply to around eighty-one-and-a-half thousand retail pharmacies and three-and-a-half thousand hospitals.”
Entero Healthcare's Rs 1,600-cr IPO biggest so far in 2024: 10 things to know before subscribing to the issue
The IPO comprises a fresh equity issue of Rs 1,000 crore and an offer for sale of up to 47.69 lakh shares. Under the OFS, Prabhat Agrawal, Prem Sethi, Orbimed Asia Iii Mauritius, Chethan MP, Deepesh T Gala, among others, will offload shares.
Entero Healthcare announces dates, price band for its Rs 1,600-cr IPO
Entero Healthcare IPO: The price band has been fixed in the range of Rs 1,195-1,258 per equity share. Bids can be made for a minimum of 11 shares and in multiples thereafter. The IPO comprises a fresh equity issue of Rs 1,000 crore and an offer for sale of up to 47.69 lakh shares. Under the OFS, Prabhat Agrawal, Prem Sethi, Orbimed Asia Iii Mauritius, Chethan MP, Deepesh T Gala, among others, will offload shares.
Load More
